Gland Pharma has reported results for second quarter ended September 30, 2022.
The company has reported a fall of 20.68% in its net profit at Rs 239.63 crore for the quarter under review as compared to Rs 302.12 crore for the same quarter in the previous year. Total income of the company decreased by 1.57% at Rs 1113.93 crore for Q2FY23 as compared Rs 1131.67 crore for the corresponding quarter previous year.
On the consolidated basis, the company has reported fall of 20.14% in its net profit at Rs 241.24 crore for the quarter under review as compared to Rs 302.08 crore for the same quarter in the previous year. Total income of the company decreased by 1.91% at Rs 1110.03 crore for Q2FY23 as compared Rs 1131.67 crore for the corresponding quarter previous year.
